Optional activities

You can get 8 credits of optional activities (ADO) participating to conferences ,seminars, workshop, journal club or internship:

  • 1 credit  25 hours of internship;
  • 0.5 credits conferences and seminars;
  • conferences and seminars of your interest can be required as credits sending an email to: : director.medicalbiotech@uniupo.it 

A.Y. 2020/2021

1.  Title ADO  Biomedical aspects of aging" (Prof. Federico Sesti -Rutgers University, USA-) - Prof. Diego Cotella 

     DIR page: https://www.dir.uniupo.it/course/view.php?id=12810

     Credits: 2  

     Date: 17-18-20 May from 3 pm to 4.45 pm

               24 -25 -27 May from 3 to 4.45 pm

      Year of enrolment: 1st and 2nd 

2. Title ADO: Progress in the development of novel therapies. Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax- Dr. Abdurraouf Mokhtar Mahmoud

Credits: 2

Date: 26  May 2021 from 2pm to 4pm 

Year of enrolment: 1st Year

2. Title ADO: How to design study protocol; example from randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study - Dr. Abdurraouf Mokhtar Mahmoud

Credits: 2

Date: 18 Jun 2021

Year of enrolment: 2nd Year

3. Title ADO: How to design study protocol; example from randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.

Date: 18 June 2021 from 2 pm to 4 pm 

Credits: 2

Year of enrolment: 2nd Year

 4. Title ADO: How to design study protocol; example from A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.

Credits: 2

Date: 28 June 2021 from 2 pm to 4 pm

Year of enrolment: 1st Year

 

5. Title ADO: Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.

Date: 09 July 2021 from 2 pm to 4 pm 

Credits: 2

Year of enrolment:  1st Year and 2nd Year

 

6 . Title ADO: KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study.

Date: 26 July 2021 from 2 to 4 pm 

Credits: 2

Year of enrolment: 1st Year and 2nd Year

 

7. Title ADO: "Omics in forensic sciences" (Dott.ssa Sarah Gino)

Dir: https://www.dir.uniupo.it/enrol/index.php?id=12851

Credits: 1

Year of enrolment: 2nd Year

Ultimo aggiornamento: 31/05/2021 - 11:48